Literature DB >> 26891253

Prediabetes and diabetes among HIV-infected adults in Cameroon.

John Y Rhee1, Tumi Divine Bahtila2, Dennis Palmer2, Pius Muffih Tih2, Judith A Aberg3, Derek LeRoith4, Jennifer Jao5.   

Abstract

BACKGROUND: Human immunodeficiency virus (HIV) and certain antiretrovirals are associated with diabetes. Few studies have examined the prevalence of and factors associated with diabetes among HIV-infected individuals on combination antiretroviral therapy (cART) in sub-Saharan Africa; some report prevalence estimates between 3.5-26.5% for diabetes in Cameroon and 20.2-43.5% for prediabetes in sub-Saharan Africa.
METHODS: In a cross-sectional study, HIV-infected individuals (16-65 years old) were screened for diabetes using haemoglobin A1c (HbA1c ). We further categorized HbA1C as normoglycemia (HbA1c  < 5.7%), prediabetes (HbA1c 5.7-6.4%) or diabetes (HbA1c   ≥ 6.5%). Dysglycemia was defined as HbA1c  ≥ 5.7%. Logistic regression modelling was used to assess factors associated with having dysglycemia.
RESULTS: Of 500 participants, 363 (72.6%) were female. Median age was 42.5 years [interquartile range (IQR): 36.5-49.5]. Nineteen patients (3.8%) had diabetes and 170 patients (34%) were classified as having prediabetes. One hundred nine (22%) had a CD4+ count <200 cells/mm(3) , and 464 (93%) had received >28 days of ART at time of screening. Median abdominal circumference for women was 79.5 cm (IQR: 75.5-85.3) and for men, 86.5 cm (IQR: 81.7-90.5). Adjusting for age, sex, socio-economic status, CD4 cell count, being on cART >28 days, body mass index, hypertension, history of hypertension, abdominal circumference and duration of HIV infection, larger abdominal circumference was associated with higher prevalence of prediabetes or diabetes (adjusted odds ratio = 1.07, 95% confidence interval: 1.03-1.11), while being on cART (adjusted odds ratio = 0.46, confidence interval: 0.22-0.99) was associated with lower prevalence.
CONCLUSIONS: There was a high prevalence of dysglycemia among Cameroonian HIV-infected adults. Larger abdominal circumference was associated with higher prevalence, while cART was associated with lower prevalence.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Cameroon; HIV; antiretroviral therapy; diabetes; prevalence

Mesh:

Substances:

Year:  2016        PMID: 26891253      PMCID: PMC5087795          DOI: 10.1002/dmrr.2792

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  12 in total

1.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

Review 2.  Waist circumference threshold values for type 2 diabetes risk.

Authors:  Karl E Friedl
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

Review 3.  A1C level and future risk of diabetes: a systematic review.

Authors:  Xuanping Zhang; Edward W Gregg; David F Williamson; Lawrence E Barker; William Thomas; Kai McKeever Bullard; Giuseppina Imperatore; Desmond E Williams; Ann L Albright
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

4.  Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment.

Authors:  L G Ekali; L K Johnstone; J B Echouffo-Tcheugui; C Kouanfack; M Y Dehayem; L Fezeu; B Nouthe; L Hayes; N C Unwin; E Sobngwi
Journal:  Diabetes Metab       Date:  2012-11-13       Impact factor: 6.041

5.  Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects.

Authors:  Rebecca Scherzer; Wei Shen; Peter Bacchetti; Donald Kotler; Cora E Lewis; Michael G Shlipak; Steven B Heymsfield; Carl Grunfeld
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

6.  Hypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional study.

Authors:  Peter M Janiszewski; Robert Ross; Jean-Pierre Despres; Isabelle Lemieux; Gabriella Orlando; Federica Carli; Pietro Bagni; Marianna Menozzi; Stefano Zona; Giovanni Guaraldi
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

7.  Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Authors:  Stephane De Wit; Caroline A Sabin; Rainer Weber; Signe Westring Worm; Peter Reiss; Charles Cazanave; Wafaa El-Sadr; Antonella d'Arminio Monforte; Eric Fontas; Matthew G Law; Nina Friis-Møller; Andrew Phillips
Journal:  Diabetes Care       Date:  2008-02-11       Impact factor: 17.152

8.  Diabetes and pre-diabetes among persons aged 35 to 60 years in eastern Uganda: prevalence and associated factors.

Authors:  Roy William Mayega; David Guwatudde; Fredrick Makumbi; Frederick Nelson Nakwagala; Stefan Peterson; Goran Tomson; Claes-Goran Ostenson
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

9.  Increased burden and severity of metabolic syndrome and arterial stiffness in treatment-naïve HIV+ patients from Cameroon.

Authors:  William Ngatchou; Daniel Lemogoum; Pierre Ndobo; Euloge Yagnigni; Emiline Tiogou; Elisabeth Nga; Charles Kouanfack; Philippe van de Borne; Michel P Hermans
Journal:  Vasc Health Risk Manag       Date:  2013-09-04

10.  Prevalence of metabolic syndrome in human immunodeficiency virus - infected patients from the South-West region of Cameroon, using the adult treatment panel III criteria.

Authors:  Herbert Afegenwi Mbunkah; Henry Dilonga Meriki; Anthony Tufon Kukwah; Omarine Nfor; Theresa Nkuo-Akenji
Journal:  Diabetol Metab Syndr       Date:  2014-08-25       Impact factor: 3.320

View more
  11 in total

1.  Metformin for Preventing Progression From Prediabetes to Diabetes Mellitus in People Living With Human Immunodeficiency Virus.

Authors:  Hataikarn Nimitphong; Sitta Jiriyasin; Pisekporn Kasemasawachanon; Somnuek Sungkanuparph
Journal:  Cureus       Date:  2022-04-27

Review 2.  Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten.

Authors:  Nazik Elmalaika Husain; Sufian K Noor; Wadie M Elmadhoun; Ahmed O Almobarak; Heitham Awadalla; Clare L Woodward; Dushyant Mital; Mohamed H Ahmed
Journal:  HIV AIDS (Auckl)       Date:  2017-11-08

3.  Presence, patterns & predictors of hypocortisolism in patients with HIV infection in India.

Authors:  Neera Sharma; Lokesh Kumar Sharma; Atul Anand; Adesh Kisanji Gadpayle; Kumar Gaurav; Sabyasachi Mukherjee; Bindu Kulshreshtha; Deep Dutta
Journal:  Indian J Med Res       Date:  2018-02       Impact factor: 2.375

4.  Prediabetes among HIV-infected individuals receiving antiretroviral therapy: prevalence, diagnostic tests, and associated factors.

Authors:  Angsana Phuphuakrat; Hataikarn Nimitphong; Sirimon Reutrakul; Somnuek Sungkanuparph
Journal:  AIDS Res Ther       Date:  2020-05-24       Impact factor: 2.250

5.  Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test - which method to choose for the diagnosis?

Authors:  Ana Rita Coelho; Flávia Andreia Moreira; Ana Cristina Santos; André Silva-Pinto; António Sarmento; Davide Carvalho; Paula Freitas
Journal:  BMC Infect Dis       Date:  2018-07-06       Impact factor: 3.090

6.  Rates and Correlates of Incident Type 2 Diabetes Mellitus Among Persons Living With HIV-1 Infection.

Authors:  Yuanfan Ye; Sadeep Shrestha; Greer Burkholder; Anju Bansal; Nathaniel Erdmann; Howard Wiener; Jianming Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-23       Impact factor: 5.555

7.  HIV and cardiovascular disease in sub-Saharan Africa: Demographic and Health Survey data for 4 countries.

Authors:  Leonard E Egede; Rebekah J Walker; Patricia Monroe; Joni S Williams; Jennifer A Campbell; Aprill Z Dawson
Journal:  BMC Public Health       Date:  2021-06-12       Impact factor: 3.295

8.  Antiretroviral therapy related adverse effects: Can sub-Saharan Africa cope with the new "test and treat" policy of the World Health Organization?

Authors:  Jobert Richie N Nansseu; Jean Joel R Bigna
Journal:  Infect Dis Poverty       Date:  2017-02-15       Impact factor: 4.520

9.  Increased risk of prediabetes among virally suppressed adults with HIV in Central Kenya detected using glycated haemoglobin and fasting blood glucose.

Authors:  Anne Njoroge; Orvalho Augusto; Stephanie T Page; Christine Kigondu; Margaret Oluka; Nancy Puttkammer; Carey Farquhar
Journal:  Endocrinol Diabetes Metab       Date:  2021-07-17

10.  Prevalence of and Risk Factors for Prediabetes in Patients Infected With HIV.

Authors:  Syed Arafath; Tavajay Campbell; Jameela Yusuff; Roopali Sharma
Journal:  Diabetes Spectr       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.